539 related articles for article (PubMed ID: 26318978)
1. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
Shinde RL; Bharkad GP; Devarajan PV
Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion.
Shinde RL; Devarajan PV
Drug Deliv; 2017 Nov; 24(1):152-161. PubMed ID: 28156175
[TBL] [Abstract][Full Text] [Related]
3. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin.
Wang S; Chen P; Zhang L; Yang C; Zhai G
J Drug Target; 2012 Dec; 20(10):831-40. PubMed ID: 22934854
[TBL] [Abstract][Full Text] [Related]
5. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
Shah B; Khunt D; Misra M; Padh H
Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
Shah B; Khunt D; Misra M; Padh H
Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
[TBL] [Abstract][Full Text] [Related]
7. Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.
Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
AAPS PharmSciTech; 2006 Jan; 7(1):E8. PubMed ID: 16584167
[TBL] [Abstract][Full Text] [Related]
8. Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion.
Long Y; Yang Q; Xiang Y; Zhang Y; Wan J; Liu S; Li N; Peng W
Pharmacol Res; 2020 Sep; 159():104795. PubMed ID: 32278035
[TBL] [Abstract][Full Text] [Related]
9. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.
Vyas TK; Babbar AK; Sharma RK; Misra A
J Drug Target; 2005 Jun; 13(5):317-24. PubMed ID: 16199375
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy.
Li Q; Zhai W; Jiang Q; Huang R; Liu L; Dai J; Gong W; Du S; Wu Q
Int J Pharm; 2015 Jul; 490(1-2):22-31. PubMed ID: 25957703
[TBL] [Abstract][Full Text] [Related]
11. Nose-to-brain delivery of tacrine.
Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
[TBL] [Abstract][Full Text] [Related]
12. Oral curcumin has anti-arthritic efficacy through somatostatin generation via cAMP/PKA and Ca(2+)/CaMKII signaling pathways in the small intestine.
Yang Y; Wu X; Wei Z; Dou Y; Zhao D; Wang T; Bian D; Tong B; Xia Y; Xia Y; Dai Y
Pharmacol Res; 2015; 95-96():71-81. PubMed ID: 25836921
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
[TBL] [Abstract][Full Text] [Related]
14. Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel.
Chen X; Zhi F; Jia X; Zhang X; Ambardekar R; Meng Z; Paradkar AR; Hu Y; Yang Y
J Pharm Pharmacol; 2013 Jun; 65(6):807-16. PubMed ID: 23647674
[TBL] [Abstract][Full Text] [Related]
15. AmyloLipid Nanovesicles: A self-assembled lipid-modified starch hybrid system constructed for direct nose-to-brain delivery of curcumin.
Sintov AC
Int J Pharm; 2020 Oct; 588():119725. PubMed ID: 32763387
[TBL] [Abstract][Full Text] [Related]
16. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
Bshara H; Osman R; Mansour S; El-Shamy Ael-H
Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
[TBL] [Abstract][Full Text] [Related]
17. A simple LC-MS/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocysticercosis.
González-Hernández I; Ruiz-Olmedo MI; Cárdenas G; Jung-Cook H
Biomed Chromatogr; 2012 Feb; 26(2):267-72. PubMed ID: 21721022
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
[TBL] [Abstract][Full Text] [Related]
19. Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.
Takayanagui OM; Bonato PS; Dreossi SA; Lanchote VL
Br J Clin Pharmacol; 2002 Aug; 54(2):125-30. PubMed ID: 12207631
[TBL] [Abstract][Full Text] [Related]
20. Microemulsion based intranasal delivery system for treatment of insomnia.
Porecha S; shah T; Jogani V; Naik S; Misra A
Drug Deliv; 2009 Apr; 16(3):128-34. PubMed ID: 19514972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
